Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Learn more about your ad choices. Visit megaphone.fm/adchoices
We're back! So what did we miss?
What has COVID cost us in 2022?
Are we going to be free of this wave by Christmas?
How do you know if a pandemic is from a lab leak?
Is this the end of China's COVID zero?
Are the waves getting smaller?
Ok, now it's off and running - how do we slow it down?
Does anyone give a rat about RATs anymore?
Has the next wave already begun?
What could the floods mean for disease outbreak?
Australia's COVID report card is in. How did we do?
New Omicron booster is here! How well will it work?
What could the end to mandatory isolation mean?
Putin isn't our only worry from Russia
COVID numbers just got a whole lot harder to interpret
How else has COVID been killing people? Taking another look at excess deaths.
Where’s my Omicron specific booster? And will it help?
Is it time to scrap COVID isolation?
The best news since January - but can it last?
How much coronavirus is coming out of your mouth?
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First from NPR